Jonathan T. Silverstein

Biography

Mr. Jonathan T. Silverstein is Independent Director at Ascendis Pharma A/S, Chairman at Intercept Pharmaceuticals, Inc., Independent Director at Roka Bioscience, Inc., Partner at OrbiMed Advisors Private Equity, Chairman at Enobia Pharma, Inc., Chairman at Cerapedics, Inc., General Partner at OrbiMed Capital GP IV LLC, and Chairman at Audentes Therapeutics, Inc. He is on the Board of Directors at Ascendis Pharma A/S, Rhythm Pharmaceuticals, Inc., Rhythm Health, Inc., Roka Bioscience, Inc., Glaukos Corp., superDimension Ltd., superDimension, Inc., Arteaus Therapeutics LLC, DFINE, Inc., Avedro, Inc., and Adicet Bio, Inc.Mr. Silverstein was previously employed as Independent Director by Relypsa, Inc., Independent Director by NxStage Medical, Inc., an Associate by Hambro Resource Development, Inc., and a Director-Life Sciences by Sumitomo Bank of California. He also served on the board at Insulet Corp., Emphasys Medical, Inc., DOV Pharmaceutical, Inc., Given Imaging Ltd., Avanir Pharmaceuticals, Inc., Predix Pharmaceuticals, Inc., Adiana, Inc., Adolor Corp., Auxillium Energy, Inc., Bioenvision, Inc., Cerexa, Inc., Gelesis, Inc., LifeCell Corp., Orthovita, Inc., and Peninsula Pharmaceuticals, Inc.He received his undergraduate degree from Denison University, a graduate degree from the University of San Diego, and an MBA from the University of San Diego.  

Research Interest

 Pharmaceuticals